Intrinsic Value of S&P & Nasdaq Contact Us

Rezolute, Inc. RZLT NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
55/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.86
+120.7%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Rezolute, Inc. (RZLT) has a negative trailing P/E of -4.3, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 2.0 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -23.31%, forward earnings yield 49.26%.

Criteria proven by this page:

  • VALUE (88/100, Pass) — analyst target implies upside (+120.7%).
  • Forward P/E 2.0 — analysts expect a return to profitability with estimated EPS of $1.76 for FY2030.
  • Trailing Earnings Yield -23.31% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 49.26% as earnings recover.
  • Analyst consensus target $7.86 (+120.7% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 54/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
55/100
SG Score
View full scorecard →
VALUE
88/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
28/100
→ Income
GROWTH
15/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — RZLT

Valuation Multiples
P/E (TTM)-4.3
Forward P/E2.0
PEG RatioN/A
Forward PEGN/A
P/B Ratio2.82
P/S Ratio0.00
EV/EBITDA-3.7
Per Share Data
EPS (TTM)$-0.81
Forward EPS (Est.)$1.76
Book Value / Share$1.23
Revenue / Share$0.00
FCF / Share$-0.74
Yields & Fair Value
Earnings Yield-23.31%
Forward Earnings Yield49.26%
Dividend Yield0.00%
Analyst Target$7.86 (+120.7%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -1.7 -0.15 2.82 0.00 -
2017 -2.3 0.12 5.47 0.00 -
2018 -0.8 -0.09 -6.32 0.00 -
2019 -0.6 0.02 10.04 0.00 -
2020 -1.3 0.02 3.63 0.00 -
2021 -5.2 0.23 4.19 0.00 -
2022 -1.4 0.08 0.39 0.00 -
2023 -2.0 0.04 0.87 0.00 -
2024 -3.2 -0.10 1.83 0.00 -
2025 -4.6 0.17 2.09 0.00 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-30.14 $0.00 $-14.94M -
2017 $-24.55 $0.00 $-20.28M -
2018 $-26.83 $0.00 $-29.86M -
2019 $-17.11 $0.00 $-30.42M -
2020 $-3.54 $0.00 $-20.33M -
2021 $-2.72 $0.00 $-20.9M -
2022 $-1.99 $0.00 $-41.06M -
2023 $-1.01 $0.00 $-51.79M -
2024 $-1.33 $0.00 $-68.46M -
2025 $-0.98 $0.00 $-74.41M -

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.76 $-0.88 – $-0.64 $385.71K $385.71K – $385.71K 7
2027 $-0.73 $-0.75 – $-0.71 $3.22M $3.22M – $3.22M 6
2028 $-0.43 $-0.66 – $-0.26 $62.79M $62.79M – $62.79M 6
2029 $-0.95 $-0.95 – $-0.95 $189.63M $189.63M – $189.63M 3
2030 $1.76 $1.76 – $1.76 $431.44M $431.44M – $431.44M 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message